NuvaWave
Steve has a track record of consistently delivering innovations to market. He has more than 63 patents to his credit and more than 20 successful medical device product introductions. Most recently, he built and led the R&D team at Tear Science, which was acquired by Johnson and Johnson Surgical Vision in 2017. There he was promoted to the head of R&D for the Dry Eye Business Unit. He has a BS in Electrical Engineering from Northeastern University and graduate-level course work from Stanford and Boston University.
This person is not in any teams
This person is not in any offices
NuvaWave
1 followers
NuvaWave™ is the world’s first instant UV disinfection device that kills 99.9%+ of pathogens with the greatest accuracy. Perfect to deal with the Covid-19 situation!